In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve ... It is better for your health to begin HIV treatment sooner, rather than later. There are some fixed-dose ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro. The FDA has approved ...

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we ... (www.talktofrank.com). Drug use can interfere with sleeping patterns and routines, making missed doses of your ...

6 They rely on complex treatment regimens, sometimes involving injectable medications in combination with multiple pills several ... conducted more than 5.1 million HIV tests from 261 ...

ViiV’s new daily HIV treatment has been ... above 12 years of age with HIV-1, and is based on a combination of dolutegravir and lamivudine given as a single pill once daily.

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

The national HIV prevalence was 16. 3% among adults aged 15 years and older, translating to an estimated 7. 4 million adults ...